Clinical trial participation and outcome for patients with glioblastoma: Multivariate analysis from a comprehensive dataset

Journal of Clinical Neuroscience

Volumn 20, Issue 6, 2013, Pages 783-789

  Field, Kathryn M ^a,b   Drummond, Katharine J ^a,c   Yilmaz, Merve ^d   Tacey, Mark ^a   Compston, Daniel ^a   Gibbs, Peter ^a,b,c   Rosenthal, Mark A ^a,c  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Clinical trial; Glioblastoma; Outcomes research; Prognosis; Survival

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BIRTHPLACE; BRAIN BIOPSY; COHORT ANALYSIS; CRANIOTOMY; DIABETES MELLITUS; FEMALE; FRONTAL LOBE; GENDER; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT PARTICIPATION; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING HABIT; SOCIAL STATUS; TUMOR LOCALIZATION; TUMOR VOLUME; AUSTRALIA; CENTRAL NERVOUS SYSTEM NEOPLASMS; CLINICAL TRIAL (TOPIC); FACTUAL DATABASE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; SURVIVAL; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT; CENTRAL NERVOUS SYSTEM TUMOR; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CENTRAL NERVOUS SYSTEM NEOPLASMS; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84891888965     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2012.09.013     Document Type: Article

References (28)

1. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459-66.
2. Rosenthal MA, Drummond KJ, Dally M, et al. Management of glioma in Victoria (1998-2000): retrospective cohort study. Med J Aust 2006;184:270-3.
3. Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352:997-1003.
4. Peppercorn JM, Weeks JC, Cook EF, et al. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet 2004;363:263-70.
5. Kosmider S, Jones I, Hibbert M, et al. Towards establishing a national colorectal cancer database: lessons learnt from Bio21 molecular medicine informatics model. ANZ J Surg 2008;78:803-9.
6. Pink B. An introduction to Socio-Economic Indexes for Areas (SEIFA). In: Statistics ABo, editors. Canberra: Australian Bureau of Statistics; 2006, p. 24-32.
7. Robinson WR, Ritter J, Rogers AS, et al. Clinical trial participation is associated with improved outcome in women with ovarian cancer. Int J Gynecol Cancer 2009;19:124-8.
8. Hebert-Croteau N, Brisson J, Lemaire J, et al. The benefit of participating to clinical research. Breast Cancer Res Treat 2005;91:279-81.
9. Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term) ? Evidence for a "trial effect". J Clin Epidemiol 2001;54:217-24.
10. Vist GE, Hagen KB, Devereaux PJ, et al. Systematic review to determine whether participation in a trial influences outcome. BMJ 2005;330:1175.
11. Report on 2009 Clinical Trial Activity in Victoria. Cancer Council Victoria, September 2010.
12. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
13. Giuliano AR, Mokuau N, Hughes C, et al. Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol 2000;10:S22-34.
14. Swanson GM, Ward AJ. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst 1995;87:1747-59.
15. Shavers VL, Lynch CF, Burmeister LF. Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol 2002;12:248-56.
16. Yu XQ, O'Connell DL, Gibberd RW, et al. Assessing the impact of socio-economic status on cancer survival in New South Wales, Australia 1996-2001. Cancer Causes Control 2008;19:1383-90.
17. Bentley R, Kavanagh AM, Subramanian SV, et al. Area disadvantage, individual socio-economic position, and premature cancer mortality in Australia 1998-2000: a multilevel analysis. Cancer Causes Control 2008;19:183-93.
18. Berglund A, Garmo H, Robinson D, et al. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer. Eur J Cancer 2012;48:75-84.
19. La Par DJ, Bhamidipati CM, Harris DA, et al. Gender, race, and socioeconomic status affects outcomes after lung cancer resections in the United States. Ann Thorac Surg 2011;92:434-9.
20. Kim J, Artinyan A, Mailey B, et al. An interaction of race and ethnicity with socioeconomic status in rectal cancer outcomes. Ann Surg 2011;253:647-54.
21. Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 2006;17:5-19.
22. Curry Jr WT, Barker 2nd FG. Racial, ethnic and socioeconomic disparities in the treatment of brain tumors. J Neurooncol 2009;93:25-39.
23. Tseng JH, Merchant E, Tseng MY. Effects of socioeconomic and geographic variations on survival for adult glioma in England and Wales. Surg Neurol 2006;66:258-63 discussion 63.
24. Schmidt LS, Nielsen H, Schmiedel S, et al. Social inequality and incidence of and survival from tumors of the central nervous system in a population-based study in Denmark, 1994-2003. Eur J Cancer 2008;44:2050-7.
25. Krex D, Klink B, Hartmann C, et al. Long-term survival with glioblastoma multiforme. Brain 2007;130:2596-606.
26. Scott JN, Rewcastle NB, Brasher PM, et al. Long-term glioblastoma multiforme survivors: a population-based study. Can J Neurol Sci 1998;25:197-201.
27. Tramacere F, Gianicolo E, Serinelli M, et al. Multivariate analysis of prognostic factors and survival in patients with "glioblastoma multiforme". Clin Ter 2008;159:233-8.
28. Helseth R, Helseth E, Johannesen TB, et al. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand 2010;122:159-67.